chrisvoncsefalvay/vaers-outcomes huggingface dataset:
She does not think this is right; Numb finger tips/Entire left arm is numb and tingling; Entire left arm is numb and tingling; Can't differentiate hot or cold water using her left arm; Magnet sticks to her left arm at the site where the vaccine was injected.; Hives at injection site; Red perfectly round circle that is slightly bigger than the size of a golf ball at the site of injection; Neck stiffness; Left arm pit is tender to touch; Left arm pit is sore; This spontaneous case was reported by a consumer and describes the occurrence of SENSORY LOSS (Can't differentiate hot or cold water using her left arm), THINKING ABNORMAL (She does not think this is right), VACCINATION SITE REACTION (Magnet sticks to her left arm at the site where the vaccine was injected.), HYPOAESTHESIA (Numb finger tips/Entire left arm is numb and tingling) and PARAESTHESIA (Entire left arm is numb and tingling) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 31-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Aug-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (Neck stiffness), TENDERNESS (Left arm pit is tender to touch) and MYALGIA (Left arm pit is sore). On 07-Sep-2021, the patient experienced VACCINATION SITE REACTION (Magnet sticks to her left arm at the site where the vaccine was injected.), VACCINATION SITE URTICARIA (Hives at injection site) and VACCINATION SITE ERYTHEMA (Red perfectly round circle that is slightly bigger than the size of a golf ball at the site of injection). On 08-Sep-2021, the patient experienced SENSORY LOSS (Can't differentiate hot or cold water using her left arm), HYPOAESTHESIA (Numb finger tips/Entire left arm is numb and tingling) and PARAESTHESIA (Entire left arm is numb and tingling). On an unknown date, the patient experienced THINKING ABNORMAL (She does not think this is right). At the time of the report, SENSORY LOSS (Can't differentiate hot or cold water using her left arm), THINKING ABNORMAL (She does not think this is right), VACCINATION SITE REACTION (Magnet sticks to her left arm at the site where the vaccine was injected.), HYPOAESTHESIA (Numb finger tips/Entire left arm is numb and tingling), PARAESTHESIA (Entire left arm is numb and tingling), MUSCULOSKELETAL STIFFNESS (Neck stiffness), TENDERNESS (Left arm pit is tender to touch), MYALGIA (Left arm pit is sore), VACCINATION SITE URTICARIA (Hives at injection site) and VACCINATION SITE ERYTHEMA (Red perfectly round circle that is slightly bigger than the size of a golf ball at the site of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.   Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 08-Sep-2021: Significant follow up received added event and outcome of events
Severe chills; Fever; Extreme nausea; Headache; Severe body aches; Agitation; Extreme fatigue; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 23Apr2021 at 14:30 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included loratadine (CLARITIN) for allergies from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 02Apr2021 at 14:30 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. On 24Apr2021 at 01:30, the patient experienced severe chills, fever, extreme nausea, headache, severe body aches, agitation and extreme fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event severe chills, fever, extreme nausea, headache, severe body aches, agitation and extreme fatigue was recovering at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
EMS called. No treatment. Pale, lost color in face, passed out, incoherent. After 10 min color came back. Pain upon moving.
Patient initially noted soreness at injection site (left arm) one-half hour later she noted "numbness" from the elbow to the fingers of the left arm.  Patient states this feels like "carpal tunnel syndrome" feels.  Patient took ibuprofen per mouth, applied ice to injection site.  Patient states that by 15:00 all "numbness has resolved. "  Patient states injection site still remains sore.
This spontaneous report as received from a physician refers to a patient of unknown age and gender. On 04-JAN-2013, the patient was vaccinated with BCG vaccine USP. No dosage information was reported. No lot number or expiration date was reported. No other co-suspects were reported. No concomitant medications were reported. The physician stated that the patient received BCG vaccine USP via the intradermal route. There were no known adverse effect. No further information was available. Follow up information received from the physician regarding the 5 month old male patient. Contact details of vaccine administrator and patient were updated the patient had no pre existing allergies. BCG vaccine USP, (lot# 4511121-A) given intradermally instead of percutaneous. On 04-JAN-2013, vaccination site became red and indurated and painful medically significant-as events required medical intervention). The patient was seen by infectious disease doctor and was started on rifampin and isoniazid to prevent any adverse reactions. The patient did not have laboratory tests performed. Area was drained on its own and is now scabbed and healing. Medication was given for 6 weeks. Prophylactic anti T.B medicines to prevent abscess or lymph node enlargement. No surgical problems or other complications. Illness at time of vaccination was none. Twin sibling was also vaccinated with the same vaccine. This is 1 of 2 reports from the same source. Additional information has been requested.
Wed Jan 13, 2021 13:54  Patient was not feeling well right after she got the vaccine. They had her sit for 15 minutes. She started to feel better and left. Started to feel bad in the car on the way back to work. Her boss is a dentist and advised her to take Benadryl, which she did.  Traveling to Hospital now.  She has not yet been seen by a physician. Current symptoms are throat constriction, hard time swallowing, and having a hard time concentrating.  She is pale and feels unwell.   Wed Jan 13, 2021 16:09  Followed up with patient.  Patient is currently in the Emergency Room at Hospital. She has so far received steroids and benadryl.   Thurs Jan 14, 2021 08:56 Followed up with the patient again.  She returned home from the first ER visit at 17:30 last night.  About 4 hours after that her heart rate became elevated again (130-140 bpm while lying down) and she was confused, lethargic, and had a HA and backache. She went back to ER last night around 21:30. They gave her more benadryl in IV and toradol for the HA. She is now on PO benadryl every 4 hours for 4 days. Symptoms today include: runny nose, feels like a mild case of flu, HA and backache. Upon awaking this morning, prior to the morning dose of benadryl, her heart rate was a little elevated. She was also told she could alternate Tylenol or ibuprofen prn and use OTC cold remedies but hasn't needed any. The doctor said she is not a candidate for the next the second vaccine dose.
I have been sick constantly since receiving the initial vaccine. I have had colds, sweats, chills etc. I felt like I had COVID all over again. I had fever chills and body aches.   I felt sick the same day. It was just a few hours after the vaccine that I became loopy and completely out of it. fluctuating temperature between 100 and 104. This is an ongoing condition that does not seem to go away. I feel like my immune system was compromised as I am coughing up phlegm and have a frequent runny nose. I had 5 migraines within weeks of receiving the vsaccine. I have developed a sensitivity to light. I have to wear sunglasses to drive.
1st dose: Pain and soreness at the injection site lasting 5 days post-injection. Moderate headache 6 hours post-injection acetaminophen was taken 8 hours post-injection.   2nd dose: Pain and soreness at injection site. Moderate headache, fatigue. 6 hours post-injection  18 hours post-injection very severe headache/migraine lasting 12 hours fatigue lasting 24-72 hours post-injection mild to moderate  muscle pain 24-72 hours post-injection mild to moderate joint pain/aches 48-72 hours post-injection mild  nausea 24-72 hours post-injection very mild    acetaminophen was taken  24 hours post-injection   rash at injection site developed 72 hours post-injection at the injection site measuring 3 inches in length and 2 inches in width with jagged edges. Is red and hot to the touch and the injection site is sore and firm very mild itch.
had received it and she does NOT think it was refrigerated prior to administration; This case was reported by a consumer via call center representative and described the occurrence of incorrect storage of drug in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.  Additional information was provided as follows:  The reporter was the patient. The age at vaccination was not reported. The patient received Shingrix, which was stored out of refrigerator, which led to incorrect storage of drug. The reporter stated that, she received the vaccine and does not think if it was refrigerated prior to administration. The reporter stated that, She saw them taking out of the box off the shelf and later when I went to look up the side effects and that needs to be refrigerated. The reporter mentioned that, she was pretty sure that it was not refrigerated.  She did not want to answer any further questions further.  She said she wanted to call the facility (right away) to find out if it was refrigerated or not.  She said she would call back and ended the call abruptly.
Patient felt dizzy, nausea, light headed and hot five minutes after vaccine. Had patient lay down for 15 minutes, VS 125/69 BP, 76 P, 16 R,, 100% O2 Patient drinking water, states she feels much better after laying down.
Headache; lethargic; Headache/lethargic, continued and progressively got worse; neck pain; kidney pain; This is a spontaneous report from a contactable nurse reported for herself. A 34-year-old non- pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: unknown), at 34 years of age, via an unspecified route of administration on 22Jan2021 14:00 at single dose, for COVID-19 immunization. The patient medical included PCOS (Polycystic ovarian syndrome). Patient had sulfa allergy. Concomitant medication included Levothyroxine, metformin, spironolactone and vitamin. On 23Jan2021, the patient experienced Headache, lethargic, continued and progressively got worse over the past 2 weeks, neck pain, kidney pain that comes and goes. The events were considered as non-serious. Events were treated with Compazine, fioricet, flexerol and Tylenol. Patient did not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient had not been tested for COVID-19 and COVID-19 test shows negative results. The outcome of the events was not recovered.    Information on batch/lot number was requested.
Full body rash appeared about 10pm the following day. I have been suffering debilitating headaches since receiving the booster on 2/5/22. It comes and goes but I am still experiencing discomfort. Rash has since dissipated, but headaches are still recurring.
COVID-19; Patient didn't receive her second dose vaccine as of day 49; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of COVID-19 (COVID-19) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.  On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced COVID-19 (COVID-19) (seriousness criterion hospitalization). On an unknown date, the patient experienced INTENTIONAL PRODUCT USE ISSUE (Patient didn't receive her second dose vaccine as of day 49). The patient was hospitalized on 25-Mar-2021 due to COVID-19. At the time of the report, COVID-19 (COVID-19) and INTENTIONAL PRODUCT USE ISSUE (Patient didn't receive her second dose vaccine as of day 49) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Mar-2021, SARS-CoV-2 test: covid-19 Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported .  It was unclear about  the duration of hospitalization.   Patient didn't receive her second dose vaccine as of day 49 due to her hospitalization.; Sender's Comments: This case concerns a 50-year-old female hospitalized with a serious unexpected event of COVID-19, and nonserious unexpected Intentional product use issue. Event onset 24 days after first dose mRNA-1273. Event outcome unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
My first dose went well. I just had a sore arm.  8 days prior to my second dose I was covered in thick hives head to toe. I went to and urgent care, the ER, saw my PCP, and got established with a dermatologist within those eight days who put me on predisone and Pepcid. Nothing was helping and the day of my second dose I still had hives all over my body, but about three hours after my shot, they were almost completely gone. Not sure if the vaccine had something to do with that or if it was a coincidence. Other than that I felt fantastic after my second dose.
5 min following vax, developed red rash around inject site (2 cm in diameter) w/mild nausea & light-headedness; Pt recovered;
A mother  reported that her child rec'd either DTP or DTaP (manufacturer unknown) and subsequently experienced hyporesponsive and flu like symptoms. The child recovered. The reporter did not indicate the number of her other children who experienced this event. Additional reports will be generated when identifying info is provided.
Breathing problems - harsh, dysphoric x 2 days then 10-19 rash noted on Lt upper thigh which has progressed to bilat knees to abdomen, bilat arms.
This spontaneous report was received from a Medical Assistant regarding a patient of unknown age and gender. The patient's medical history, drug reactions, allergies and concurrent conditions were not reported. On 22-JUN-2015, the patient was vaccinated with a dose of an improperly stored GARDASIL, (dose, route, anatomica location, lot number and expiration date were not reported). There was no concomitant medication reported. No adverse effects reported. This is one of several reports from the same source. Additional information has been requested.
No adverse event; Expired doses administered to patients; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired doses administered to patients) and NO ADVERSE EVENT (No adverse event) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 prophylaxis.     No Medical History information was reported.    In 2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. In 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired doses administered to patients). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired doses administered to patients) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired doses administered to patients).    No concomitant medication was provided.  It was reported that date the vial was initially stored in the refrigerator was 07 Jun 2022. Number of doses/vials were 35 doses and 4 vials.The vial did not undergo any temperature excursions. Date of administration of the vaccines: 1 Apr 2022, 5 Apr 2022, 6 Apr 2022, 8 Apr 2022, 11 Apr 2022, 12 Apr 2022, 13 Apr 2022, 14 Apr 2022, 22 Apr 2022, 9 Jun 2022,10 Jun   2022, 13 Jun 2022, 18 Jun 2022 and 22 Jun 2022.  Treatment medication was not provided by the reporter.
Pt came on 4/23/21 to get her second dose Moderna COVID vaccine.  She has an ongoing history of urticaria.  She requested and was given 25 mg of benadryl.  It was authorized by Dr.  She was observed for 30 minutes without any symptoms.
Expired Booster doses administered >12 hours post puncture; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired Booster doses administered >12 hours post puncture) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 056M21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired Booster doses administered >12 hours post puncture). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired Booster doses administered >12 hours post puncture) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. On 20APR2022 vial was initially stored in the refrigerator. On 21APR2022 at 8:45AM Date and time vial was first punctured. Concomitant medications were not reported. Treatment medications were not reported.
This case was reported by a healthcare professional and described the occurrence of injection site lump in a 57-year-old male subject who was vaccinated with BOOSTRIX (GlaxoSmithKline). Concurrent medical conditions included allergy to morphine, ROCEPHIN allergy and metal plate in arm. Concurrent vaccination included seasonal influenza vaccine (non-gsk); Sanofi Pasteur; unknown; left arm given on 27 January 2012. Concurrent medications included Simvastatin, DIOVAN, Metformin, Metoprolol, TRILIPIX, Glimepiride, Venlafaxine and aspirin. On 27 January 2012 between 09:50 and 10:00, the subject received a dose of BOOSTRIX (.5 cc, unknown route, right arm). On 29 January 2012, 2 days after vaccination with BOOSTRIX, the subject experienced lump or knot at injection site, extreme pain at injection site, "injection more painful with movement" and redness at injection site. It was reported that the subject has a metal plate in his arm in the area where the BOOSTRIX vaccine was administered. It was noted that the flu vaccine was administered in the opposite arm. The subject was treated with ibuprofen. At the time of the reporting, all the events were unresolved. The healthcare professional considered all the events were probably related to vaccination with BOOSTRIX.
Mom states that the day after this child received immunizations, he broke out in a rash that started on his legs where the shots were given and it spread to his whole body.  The rash looked "blistery with white centers".  The rash disappeared later that day for the most part.  Mom states that there was no fever or difficulty breathing.  No other s/s of illness or distress.
Information has been received from a consumer, who is a nurse, concerning her 4 year old daughter who in March 2006, was vaccinated IM with a dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wister RA 27/3) (lot # 649812/0492R). In March 2006, the patient experienced redness and swelling at the injection site. It was noted that the child's arm was twice it's size and the reporter was concerned it may be cellulitis. This happened over a weekend and the physician on call suggested diphenhydramine hcl (BENADRYL). ibuprofen (MOTRIN) and warm packs. The child responded to this  treatment and the swelling subsided in 3 days. It was reported that she recovered in March 2006.  No product quality complaint was involved. The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory. The lot met the requirements of the Center for Biologics and Evaluation Research and was released by the regulatory agency. Additional information has been requested.
Headache & NauseaVomiting Narrative:  SYMPTOMS FOR 2 DAYS ON AND OFF: HEADACHE, NAUSEA/VOMITING  Other Relevant History:
This spontaneous report was received from a registered nurse refers to a patient of unknown demographics. The patient was vaccinated with dose 1 GARDASIL injection 20 micrograms (mcg)-40 mcg-40 mcg-20 mcg/0.5 millimeters (ML) 1 standard package syringe of 0.5 on 15-JUN-2011. No concomitant medications were reported. Nurse reported that patient received second dose of GARDASIL outside of recommended dosing schedule on 14-JUN-2012. No adverse effects reported. No additional information provided. Additional information has been requested.
Developed severe purpuric "rash" on legs diagnosed by dermatologist as hypersensitivity vasculitis most likely cause being Tdap vaccine. Treated with steroids. Then dealt with severe joint inflammation lasting for more than a month. With occasional vasculitis flares affecting the lower legs.
EXTREMELY TIRED Narrative:   EXTREMELY TIRED-SLEPT ALL NIGHT INTO THE NEXT DAY
on 10/19/2020 at 9:53am, MMR vaccine administer to right arm SubQ. Almost immediately site was red, swollen, & warm to touch. Patient given an ice pack and monitored for 30 minutes.
Immediately following the shot, I felt dizzy and had a vasovagal syncope. Hours after, chills, abdominal pain, muscle pain, fever, headache, nausea. This symptoms lasted four days.
Second dose was given 7/29/21. Booster was given 11/17/2021 by RN.  This is less than 4 months. Has not met 6 month requirement for booster.